The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.

2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. 

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

Across industries, more than a third of the time saved by AI gets eaten by overstretched humans who have to clean up the technology’s sloppy work. 

The tech giant is making each model publicly available so that researchers and developers can have access to the updated technology. 

The entrepreneur took to X this week to tout his accomplishment, which was achieved with the help of Anthropic’s Claude AI.